关于我们标题

泰格捷通

泰格捷通是泰格医药（股票代码：300347.SZ/3347.HK）全资子公司，成立于2000年，是中国领先的医疗器械(含体外诊断产品)法规事务及临床研究CRO，覆盖医疗器械各领域全生命周期。在过去的20年中我们与来自30多个国家的1900多家医疗器械研发及生产企业建立了长期合作关系，以我们专业的服务能力为客户降低注册风险、缩短项目周期、节约研发经费，推进产品市场化进程。

Global Layout

Supported by Tigermed Group, we have more than 180+ offices in major cities on five continents worldwide，covering major medical device markets such as the United States, Europe, and Asia Pacific.

Learn More

Development History

Leading provider of regulatory affairs and clinical research CRO services for medical devices (including in vitro diagnostic products)

2023
Implementing a global strategy for the full lifecycle of medical devices
2022
Est. of Tigermed-Jyton Software Testing Lab in Suzhou
2020
Deepening Specialization in various therapeutic areas
2017
Resource Synergy with Tigermed
2015
Est. of Tigermed-Jyton Testing Lab in Hangzhou
2012
Obtained ISO 9001 certification
2010
Expand global markets
2004
1000 medical device products marketing support
2000
Company foundation

Company Qualification and Compliance

National High-tech Enterprise
ISO9001
CNAS/CMA

关于我们

致力于成为最具影响力的医疗器械CRO公司

泰格捷通

Global Layout

Supported by Tigermed Group, we have more than 180+ offices in major cities on five continents worldwide，covering major medical device markets such as the United States, Europe, and Asia Pacific.

Development History

Leading provider of regulatory affairs and clinical research CRO services for medical devices (including in vitro diagnostic products)

Company Qualification and Compliance

Advance Human Health through
Delivery Excellence

Subscribe to Receive Tigermed-Jyton's Regulatory Newsletter

关于我们

致力于成为最具影响力的医疗器械CRO公司

泰格捷通

Global Layout

Supported by Tigermed Group, we have more than 180+ offices in major cities on five continents worldwide，covering major medical device markets such as the United States, Europe, and Asia Pacific.

Development History

Leading provider of regulatory affairs and clinical research CRO services for medical devices (including in vitro diagnostic products)

Company Qualification and Compliance

Advance Human Health throughDelivery Excellence

Subscribe to Receive Tigermed-Jyton's Regulatory Newsletter

Advance Human Health through
Delivery Excellence